Rigel Pharmaceuticals, Inc. earnings per share and revenue

RIGL earnings per share for the last quarter are -0.06 USD whereas the estimation was -0.29 USD which accounts for 79.46% surprise. Company revenue for the same period amounts to 36.84 M USD despite the estimated figure of 33.42 M USD. Estimated earnings per share for the next quarter are 0.06 USD, and revenue is expected to reach 41.94 M USD. Also watch annual changes over time to get a bigger picture of RIGL earnings per share and revenue dynamics.